Table 3.
Laboratory tests before and 4–6 weeks after treatment.
| Laboratory test | Pretreatment | 4–6 weeks after treatment | P valuea |
|---|---|---|---|
| Total bilirubin (μmol/L) | 12.2 ± 6.3 | 20.9 ± 41.6 | 0.006 |
| Albumin (g/L) | 42.3 ± 4.8 | 41.4 ± 5.4 | 0.126 |
| Alanine transaminase (U/L) | 31.3 ± 27.6 | 37.4 ± 44.0 | 0.354 |
| Aspartate aminotransferase (U/L) | 37.8 ± 42.0 | 42.4 ± 52.6 | 0.499 |
| Prothrombin time (s) | 12.2 ± 1.2 | 12.5 ± 1.6 | 0.221 |
| International normalized ratio | 1.1 ± 0.1 | 1.1 ± 0.1 | 0.163 |
| Red blood cell count (x 1012/L) | 4.4 ± 0.7 | 4.3 ± 0.7 | 0.470 |
| Hemoglobin (g/L)) | 133.4 ± 21.5 | 130.1 ± 23.0 | 0.215 |
| Platelet count (x 109/L) | 181.0 ± 91.1 | 180.3 ± 91.6 | 0.993 |
| White blood cell count (x 109/L) | 5.8 ± 2.4 | 6.2 ± 3.7 | 0.558 |
| Neutrophil to lymphocyte ratio | 3.0 ± 2.5 | 4.1 ± 5.1 | 0.043 |
a
Wilcoxon signed-rank test was used for statistical analyses.